Entero Therapeutics Welcomes Timothy Ramdeen to Board
Company Announcements

Entero Therapeutics Welcomes Timothy Ramdeen to Board

Entero Therapeutics (ENTO) just unveiled an announcement.

Timothy R. Ramdeen, a seasoned professional with nearly a decade of experience in private equity, hedge fund investing, and company formation, has been appointed to the Board of a company. He is the founder of Dharma Capital Advisors and has played significant roles in various investment and biotechnology firms, including Sixth Borough Capital Management and Amplexd Therapeutics. Ramdeen, who holds a B.S. in Biology and an MBA in Finance, adds considerable life science industry expertise to the Board. Additionally, the company has seen recent changes to its Audit and Compensation Committees following the resignations of previous members, with new appointments to fill these roles.

Find detailed analytics on ENTO stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskEntero Therapeutics Strikes Deal for Drug Trial Compliance Tech
TheFlyEntero Therapeutics signs letter of intent with Data Vault Holdings
TheFlyEntero Therapeutics receives noncompliance notification from Nasdaq
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App